Terms: = Kidney tumors AND ENO2, HEL-S-279, NSE
104 results:
1. eno2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract] [Full Text] [Related]
2. Rare renal cell carcinoma with haemangioblastoma-like features and leiomyomatous stroma: report of a unique case with TSC2 and SETD2 variations.
Kong J; Tao J; Wang Q; Zhang Q; Yin L
World J Surg Oncol; 2022 Dec; 20(1):395. PubMed ID: 36510186
[TBL] [Abstract] [Full Text] [Related]
3. Integrated Analysis of the Role of Enolase 2 in Clear Cell Renal Cell Carcinoma.
Pan J; Jin Y; Xu X; Wei W; Pan H
Dis Markers; 2022; 2022():6539203. PubMed ID: 36419844
[TBL] [Abstract] [Full Text] [Related]
4. Primary Renal Well-Differentiated Neuroendocrine tumors: Analyis of Six Cases from a Tertiary Care Center in North India with Review of Literature.
Kumari N; Verma R; Agrawal V; Singh UP
Int J Surg Pathol; 2023 Sep; 31(6):982-992. PubMed ID: 35903907
[TBL] [Abstract] [Full Text] [Related]
5. Neuron-Specific Enolase and Hemoglobin as Risk Factors of Intraocular Metastasis in Patients with Renal Cell Carcinoma.
Li QY; Su T; Shi WQ; Fang JW; Zhang MY; Xu QH; Liang RB; Ge QM; Li B; Shao Y
Dis Markers; 2022; 2022():2883029. PubMed ID: 35502301
[TBL] [Abstract] [Full Text] [Related]
6. Serum markers change for intraocular metastasis in renal cell carcinoma.
Sun T; Tang J; Pan YC; Yu CY; Li B; Zhang LJ; Shu HY; Ge QM; Shao Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34467977
[TBL] [Abstract] [Full Text] [Related]
7. Sporadic hemangioblastoma of the kidney: a clinicopathologic study of three cases and a literature review.
Xu Y; Ma X; Ma Y; Li J; Zhang R; Li X
J Int Med Res; 2021 Jul; 49(7):3000605211027774. PubMed ID: 34256639
[TBL] [Abstract] [Full Text] [Related]
8. Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Zhang Y; Chen M; Liu M; Xu Y; Wu G
Oxid Med Cell Longev; 2021; 2021():6699808. PubMed ID: 33564363
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of enolase 2 is associated with worsened prognosis and increased glycikolysis in papillary renal cell carcinoma.
Sun C; Liu M; Zhang W; Wang S; Qian G; Wang M; Zhang G
J Cell Physiol; 2021 May; 236(5):3821-3831. PubMed ID: 33135164
[TBL] [Abstract] [Full Text] [Related]
10. [Comprehensive treatment of adrenal cortical carcinoma].
Deng JH; Li HZ; Ji ZG; Zhang YS; Liu GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):298-301. PubMed ID: 30996372
[TBL] [Abstract] [Full Text] [Related]
11. Asynchronous tumour quadruplicity: rectosigmoid adenocarcinoma, renal cell carcinoma, prostate adenocarcinoma and neuroendocrine small-cell lung cancer - a case report.
Adwan R; Prošvic P; Prošvicová J; Tomšová M
Rozhl Chir; 2018; 97(9):427-431. PubMed ID: 30470124
[TBL] [Abstract] [Full Text] [Related]
12. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract] [Full Text] [Related]
13. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Mjønes P; Sagatun L; Nordrum IS; Waldum HL
J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
[TBL] [Abstract] [Full Text] [Related]
14. Expression of erythropoietin and neuroendocrine markers in clear cell renal cell carcinoma.
Mjønes PG; Nordrum IS; Qvigstad G; Sørdal Ø; Rian LL; Waldum HL
APMIS; 2017 Mar; 125(3):213-222. PubMed ID: 28233444
[TBL] [Abstract] [Full Text] [Related]
15. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract] [Full Text] [Related]
16. [Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases].
Xi CG; Fan Y; Yang XY; Liu LB; Wang JH; Hu S; Li YY; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):598-602. PubMed ID: 29263496
[TBL] [Abstract] [Full Text] [Related]
17. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract] [Full Text] [Related]
18. [Neuroendocrine tumors of the kidneys].
Moch H
Pathologe; 2015 May; 36(3):278-82. PubMed ID: 25898936
[TBL] [Abstract] [Full Text] [Related]
19. Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.
Miolo G; Ash A; Buonadonna A; Lo Re G; Torrisi E; Cervo S; Santeufemia DA; Tuzi A; Canzonieri V
Cancer Biol Ther; 2014; 15(11):1439-43. PubMed ID: 25482943
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathologic characteristics of sporadic renal hemangioblastoma].
Guo J; Li L; Zhao LH; Li Y; Wang LS; Xiao L; Zhang RY
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):679-82. PubMed ID: 24433731
[TBL] [Abstract] [Full Text] [Related]
[Next]
